1. Introduction {#sec1}
===============

Immunoglobulin G4-related disease (IgG4-RD) is a recently discovered inflammatory condition characterized by IgG4-mediated fibroinflammation and enlargement of the affected organ \[[@B1]\]. While the notion of IgG4-RD was first recognized in the context of autoimmune pancreatitis \[[@B2]\], the disease has since been connected to inflammatory processes in many other organs, including the orbit and the eye \[[@B3]\]. IgG4-related ophthalmic disease (IgG4-ROD) is the term coined for instances of IgG4-RD resulting in inflammation of the ocular adnexa. IgG4-ROD has multiple clinical presentations, most frequently involving the lacrimal gland, extraocular muscles, orbital bones, and sclera \[[@B4]\]. Few case reports document meningeal involvement and even fewer present with alternative ocular pathology. We report an atypical case of IgG4-ROD presenting as aseptic meningitis and panuveitis.

2. Case Report {#sec2}
==============

A 35-year-old male with no prior medical or ophthalmic history presented with headaches, altered mental status, and fever of unknown origin. An extensive work-up for infectious, inflammatory, and neoplastic causes was noncontributory. Labs revealed marked elevations in both erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), indicating an underlying inflammatory process. Computer tomography (CT) scan of the head showed diffuse inflammation and thickening of the meninges ([Figure 1](#fig1){ref-type="fig"}). Lumbar puncture (LP) revealed an elevated white count with lymphocytic predominance. He was discharged on a course of oral acyclovir for presumed aseptic meningitis.

The patient initially improved; however, two weeks after discharge, bilateral eye pain, redness, and photophobia prompted his first visit to the ophthalmology clinic. Slit lamp exam was notable for grade 2 anterior chamber cells with flare in both eyes. The right eye showed posterior synechiae with pigment on the anterior lens capsule ([Figure 2](#fig2){ref-type="fig"}) while the left eye showed synechiolysis with a residual pigmentary ring on the anterior lens capsule ([Figure 3](#fig3){ref-type="fig"}). Dilated fundus exam was within normal limits. He was given topical prednisolone and cyclopentolate for a diagnosis of bilateral anterior uveitis. In addition to his preexisting work-up, quantitative immunoglobulin serology including IgG4 levels was also added given the unexplained systemic inflammation.

At follow-up, his symptoms persisted with a decrease in vision from 20/20 in both eyes to 20/25. He was found to have increased ocular inflammation with persistent anterior chamber cells and subsequent vitreitis and bilateral optic nerve head edema in both eyes (Figures [4](#fig4){ref-type="fig"} and [5](#fig5){ref-type="fig"}). Optical coherence tomography (OCT) was normal in the right eye but showed subclinical parafoveal thickening in the left eye ([Figure 6](#fig6){ref-type="fig"}). Fundus fluorescein angiography (FFA) confirmed posterior retinal involvement with bilateral parafoveal late vascular staining (Figures [7](#fig7){ref-type="fig"} and [8](#fig8){ref-type="fig"}).

Serology titers for IgG revealed a significant elevation in IgG subclass 4 (IgG4) at 251 mg/dL. A presumed diagnosis of bilateral panuveitis secondary to IgG4-ROD was made. The patient was offered a vitreous biopsy to further confirm the diagnosis, but he declined. He was treated with high dose oral prednisone at 60 mg/day with full resolution in anterior chamber cells, optic nerve head edema (Figures [9](#fig9){ref-type="fig"} and [10](#fig10){ref-type="fig"}), and OCT macular swelling ([Figure 11](#fig11){ref-type="fig"}). The patient\'s visual acuity returned to 20/20 after treatment.

3. Discussion and Conclusion {#sec3}
============================

IgG4-RD is an increasingly recognized immune-mediated condition that can yield destructive inflammation and fibrosis in a number of organs \[[@B1]\]. When the disease manifests in the eye as IgG4-ROD, it typically presents with lacrimal gland, extraocular muscle, and, less commonly, eyelid, orbital bone, or scleral involvement \[[@B3]\]. These manifestations can mimic many other conditions, including neoplastic, infectious, and inflammatory diseases. Thus, these require exclusion before a final diagnosis of IgG4-RD can be entertained. Diagnostic criteria put forth by Umehara et al. for IgG4-RD and by Goto et al. for IgG4-ROD can help characterize definitive, probable, and possible IgG4 disease \[[@B5], [@B6]\]. Furthermore, Yu et al. determined that the optimal cutoff value of IgG4 serum for the diagnosis of IgG4-RD is 248 mg/dL, with a sensitivity and specificity of 77.6% and 92.8%, respectively \[[@B7]\]. They subsequently concluded that 2 or 3 times the upper limit of the normal range of IgG4 level, as was found in the present case, is a useful marker for the diagnosis of IgG4-RD \[[@B7]\]. While serum IgG4 elevated levels significantly aid in the diagnosis, the gold standard for a definitive diagnosis is tissue biopsy. Using serological cut-offs like those put forth by Yu et al. is advantageous in situations when biopsy is difficult or when the patient declines, as in this case.

Here, we describe a rare case of probable IgG4-ROD presenting as meningitis and progressive panuveitis that required an extensive work-up to identify. While IgG4-RD is typically diagnosed by rheumatological specialties, we advise ophthalmologists to consider IgG4-ROD and to add IgG serology to the work-up in cases of idiopathic inflammation. When the presentation varies beyond the expected, the risk of misdiagnosing the condition heightens, which can be detrimental to the patient\'s capacity for recovery. A condition like IgG4-ROD can offer an opportunity for elevated collaboration between ophthalmology and rheumatology for a final diagnosis. Despite favorable responses to steroids, long-term management of relapsing IgG4-RD and igG4-ROD patients can be challenging, further supporting the need for awareness and multidisciplinary cooperation as it may require immunomodulatory therapy.
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![CT Scan showing diffuse inflammation and thickening of the meninges.](CRIOPM2019-5653282.001){#fig1}

![External photo of the left eye following synechiolysis with pigmentary ring on the anterior lens capsule.](CRIOPM2019-5653282.002){#fig2}

![External photo of the right eye demonstrating posterior synechiae with pigment on the anterior lens capsule.](CRIOPM2019-5653282.003){#fig3}

![Fundus photo of the left eye demonstrating optic nerve head edema with flame hemorrhages along the inferior vascular arcade (white arrows).](CRIOPM2019-5653282.004){#fig4}

![Fundus photo of the right eye demonstrating optic nerve head edema.](CRIOPM2019-5653282.005){#fig5}

![OCT Macula of the left eye demonstrating para-foveal macular thickening.](CRIOPM2019-5653282.006){#fig6}

![Fundus fluorescein angiography of the left eye showing para-foveal late vascular leakage (white arrows) and blockage from flame-hemorrhages.](CRIOPM2019-5653282.007){#fig7}

![Fundus fluorescein angiography of the right eye showing para-foveal late vascular leakage (white arrows).](CRIOPM2019-5653282.008){#fig8}

![Fundus photo of the left eye after treatment showing resolution of the optic nerve head edema.](CRIOPM2019-5653282.009){#fig9}

![Fundus photo of the right eye after treatment showing resolution of the optic nerve head edema.](CRIOPM2019-5653282.010){#fig10}

![OCT Macula of the left eye after treatment demonstrating improved para-foveal macular thickening.](CRIOPM2019-5653282.011){#fig11}
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